Impact of Leukoaraiosis Severity on the Association of Time to Successful Reperfusion with 90-Day Functional Outcome After Large Vessel Occlusion Stroke.
ASPECTS
Collaterals
Endovascular thrombectomy
Large vessel occlusion
Leukoaraiosis
Recanalization
Small vessel disease
Journal
Translational stroke research
ISSN: 1868-601X
Titre abrégé: Transl Stroke Res
Pays: United States
ID NLM: 101517297
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
05
10
2018
accepted:
27
03
2019
revised:
22
01
2019
pubmed:
14
4
2019
medline:
27
7
2021
entrez:
14
4
2019
Statut:
ppublish
Résumé
The chance for a favorable outcome after mechanical thrombectomy (MT) for large vessel occlusion stroke decreases with the symptom onset-to-reperfusion time (OTR). Patients with severe leukoaraiosis are at increased risk for a poor outcome after MT. However, whether leukoaraiosis modulates to the association between OTR and 90-day functional outcome is uncertain. We retrospectively analyzed 144 consecutive patients with successful (TICI ≥ 2b/3) MT for anterior circulation large vessel occlusion within 24 h form OTR between January 2012 to November 2016. Leukoaraiosis was dichotomized to absent-to-mild (van Swieten scale score 0-2) versus moderate-to-severe (3-4) as assessed on admission head CT. Multiple linear, logistic, and ordinal regression analyses were used to determine the association between leukoaraiosis, OTR, and 90-day modified Rankin Scale (mRS) score, after adjustment for pertinent covariates. Leukoaraiosis was independently associated with the OTR on multivariable linear regression (p = 0.003). The association between OTR and 90-day outcome depended on the degree of pre-existing leukoaraiosis burden as shown by a significant leukoaraiosis-by-OTR interaction on multivariable logistic regression (OR 0.76, 95% CI 0.58-0.98, p = 0.037) and multivariable ordinal regression (OR 0.87, 95% CI 0.78-0.97, p = 0.011). Pre-existing leukoaraiosis is associated with the 90-day functional outcome after successful reperfusion and impacts the association between the OTR and 90-day mRS among patients undergoing MT. Patients with high leukoaraiosis burden need to present earlier than patients with low leukoaraiosis burden for a similar favorable outcome. Pending confirmation, these results may have important implications for optimizing patient selection for acute stroke therapies.
Identifiants
pubmed: 30980282
doi: 10.1007/s12975-019-00703-0
pii: 10.1007/s12975-019-00703-0
pmc: PMC6925352
mid: NIHMS1063046
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-49Subventions
Organisme : NINDS NIH HHS
ID : K08 NS091499
Pays : United States
Organisme : NINDS NIH HHS
ID : K08NS091499
Pays : United States
Références
Stroke. 2011 Aug;42(8):2276-9
pubmed: 21680905
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Lancet. 2000 May 13;355(9216):1670-4
pubmed: 10905241
Cerebrovasc Dis. 2012;33(6):525-31
pubmed: 22538962
Neurology. 2017 May 30;88(22):2123-2127
pubmed: 28455382
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Neurology. 2017 Feb 14;88(7):638-645
pubmed: 28130468
Stroke. 2014 Jul;45(7):2036-40
pubmed: 24876081
Stroke. 2013 May;44(5):e43
pubmed: 23463756
Stroke. 2017 Sep;48(9):2621-2627
pubmed: 28794271
Stroke. 2008 May;39(5):1409-13
pubmed: 18340093
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
J Stroke. 2017 May;19(2):121-130
pubmed: 28592779
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Stroke. 2014 Feb;45(2):479-85
pubmed: 24370756
World Neurosurg. 2018 Dec;120:e976-e983
pubmed: 30196176
Stroke. 2012 Jul;43(7):1806-11
pubmed: 22581819
Stroke. 2017 Oct;48(10):2892-2894
pubmed: 28887393
Stroke. 2003 Aug;34(8):e109-37
pubmed: 12869717
Neuroepidemiology. 2013;40(1):13-22
pubmed: 23075702
Stroke. 2006 Mar;37(3):836-40
pubmed: 16439704
J Neurointerv Surg. 2019 Feb;11(2):137-140
pubmed: 30045947
Stroke. 2018 Feb;49(2):498-500
pubmed: 29242390
Neurology. 2006 Jan 10;66(1):23-9
pubmed: 16401840
Int J Stroke. 2017 Oct;12(8):896-905
pubmed: 28946832
Int J Stroke. 2019 Jan;14(1):23-31
pubmed: 30188259
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1080-3
pubmed: 2292703
Stroke. 2016 Oct;47(10):2526-33
pubmed: 27633020
Stroke. 2015 Oct;46(10):3020-35
pubmed: 26123479
AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2070-5
pubmed: 24994827
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2014 Mar;45(3):689-95
pubmed: 24523039
Stroke. 2013 Jan;44(1):61-7
pubmed: 23233384
Front Neurol. 2017 Mar 14;8:98
pubmed: 28352248
J Neurol. 2017 Mar;264(3):448-452
pubmed: 28004198
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
J Neurointerv Surg. 2019 Jul;11(7):670-674
pubmed: 30530773
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Int J Stroke. 2017 Aug;12(6):641-652
pubmed: 28569123
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852